Track record · closed signal

Innoviva Inc (INVA) — closed signal from March 17, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on June 15, 2026.

Predicted vs. what happened

INVA price · publication thesis → realized outcomesplit-adjusted
$22.31 Published $24.54 Target $22.42 Window close $24.45 Peak
$21.70 – $22.60Entry zone — fair-value band
$22.31Published — price the day we called it
$24.54Target — the price the thesis aimed for
$24.45Peak — highest point inside the window, not a realized return
$22.42Window close — end-of-window price, context only

What happened

Target reached

Hit or exceeded the predicted growth inside the window.

Peak price
$24.45
peak on April 20, 2026 — not a realized return
Peak gain
+9.6%
peak, from the publication price
Window close
$22.42
end-of-window price, context only
Days to target
Window
March 17, 2026 – June 15, 2026

The thesis — published March 17, 2026

Predicted growth
+10%
over the measurement window
Target price
$24.54
the price the thesis aimed for
Entry zone
$21.70 – $22.60
the fair-value band we waited for
Price at publication
$22.31
published March 17, 2026
Confidence
63%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Innoviva looks like a solid smaller biotech: it is buying back shares and building an infectious-disease business. Analysts and company updates are positive. But the stock trades very thinly, which can make buying or selling risky for short-term users. Interesting idea, but not the best choice for short-term action.

Primary drivers

  • Share buybacks and growth plan boost the company's outlook
  • Analyst comments give useful outside validation
  • Stronger balance sheet than many small biotech peers
  • Very light trading can make buying or selling unreliable

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.